Recent Updates
Recently added Catalysts
QNRX Positive Sentiment Score: 70/100

Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024

Thursday, May 2, 2024 1 min read
Key Takeaway: Quoin Pharmaceuticals Ltd. has announced that it will release its first quarter 2024 financial results on May 9, 2024, prior to market opening. This announcement is expected to include key operational updates and financial highlights from the quarter. The company focuses on developing therapeutics for rare and orphan diseases, emphasizing its commitment to address unmet medical needs.

Market Sentiment Analysis

POSITIVE FACTORS

  • Upcoming financial results may indicate strong performance.
  • Operational updates may highlight significant achievements.
  • Commitment to rare and orphan diseases is a strong market focus.

Full Press Release Details

ASHBURN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company plans to release its first quarter 2024 financial results before the market opens on Thursday, May 9, 2024.
The announcement will provide an operational update regarding the company’s achievements during the quarter, and will detail financial highlights.
About Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises four products in development that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Scleroderma, Epidermolysis Bullosa and others. For more information, visit: www.quoinpharma.com or LinkedIn for updates.
For further information, contact:
jramson@pcgadvisory.com

Tags

Frequently Asked Questions

When will Quoin Pharmaceuticals release Q1 2024 financial results?

Quoin Pharmaceuticals plans to release its Q1 2024 financial results on May 9, 2024.

What is the focus of Quoin Pharmaceuticals?

Quoin Pharmaceuticals focuses on developing treatments for rare and orphan diseases.

How many products are in Quoin's pipeline?

Quoin has four products in development targeting various rare and orphan diseases.

What conditions does Quoin's pipeline address?

Quoin's pipeline targets conditions like Netherton Syndrome and Epidermolysis Bullosa.

Where can I find more information about Quoin Pharmaceuticals?

For more details, visit Quoin's website or follow them on LinkedIn.

Tags: QNRX Viatris Investor Conferences Healthcare Quoin Pharmaceuticals financial results rare diseases orphan diseases
Last updated: May 2, 2024